MEK-inhibitors/arsenic trioxide combination therapy as a novel treatment option for tyrosine kinase inhibitors-resistant ph+-leukemia
Congress of the Italian Society of Experimental Hematology (16th : Napoli, Italy : October 15-17, 2020) Haematologica . – Vol. 105 s2 (2020) . –…
Leggi di più